下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响*

doi:10.12047/j.cjap.5868.2019.119

中国应用生理学杂志 ›› 2019, Vol. 35 ›› Issue (6): 543-547.doi: 10.12047/j.cjap.5868.2019.119

下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响^*

颜新建¹, 李高峰^1△, 唐梅¹, 杨小平²

1. 中南大学湘雅医学院附属株洲医院肿瘤科, 湖南株洲 412000;
2. 湖南师范大学医学院小分子靶向药物研究与创制湖南省重点实验室, 湖南长沙 410013

收稿日期:2019-04-19 出版日期:2019-11-28 发布日期:2020-04-02
通讯作者: 湖南省自然科学基金资助项目(2018JJ4097)

Effect of down-regulation of fatty acid synthase expression on proliferation, migration and invasion of bladder carcinoma UMUC3 cell lines

YAN Xin-jian¹, LI Gao-feng¹, TANG Mei¹, YANG Xiao-ping²

1. Department of Medical Oncology, the Affiliated Zhuzhou Hospital Xiangya Medical College Central South University, Zhuzhou 412000;
2. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine Hunan Normal University, Changsha 410013, China

Received:2019-04-19 Online:2019-11-28 Published:2020-04-02

摘要/Abstract

摘要： 目的: 研究脂肪酸合成酶(FASN)表达对膀胱癌UMUC3细胞增殖、迁移、侵袭的影响,探讨其内在可能机制。方法:免疫组化法检测30例膀胱癌和15例正常膀胱组织FASN蛋白的表达;用脂质体2000分别转染FASN siRNA和无义siRNA至UMUC3细胞,筛选、鉴定siFASN和siControl稳定的细胞,siFASN组细胞设为实验组,siControl组设为对照组;采用蛋白印迹法(Western blot)和实时荧光定量PCR(RT-PCR)法分别检测siFASN组和siControl组细胞FASN蛋白及mRNA的表达,MTT法检测siFASN组和siControl组细胞增殖情况,划痕试验、Transwell试验分别检测siFASN组和siControl组细胞迁移、侵袭能力。结果:FASN蛋白在膀胱癌组织中过表达,且与病理分期、分级密切相关(P＜0.05)。与siControl组相比,siFASN组细胞FASN mRNA及蛋白表达下调(P＜0.05),细胞增殖活力明显下降(P＜0.05),迁移能力明显下降(P＜0.05),穿膜细胞数量明显减少(P＜0.05)。结论:FASN过表达在膀胱癌发生、发展中发挥重要作用,下调FASN表达能抑制膀胱癌细胞的增殖、迁移、侵袭能力,抑制FASN表达有望成为一种新的膀胱癌治疗方法。

关键词: 脂肪酸合成酶, 膀胱癌, 细胞增殖, 细胞迁移, 细胞侵袭

Abstract: Objective: To investigate the effects of fatty acid synthase (FASN) on proliferation, migration and invasion of bladder cancer UMUC3 cell lines and possible mechanism. Methods: The expression levels of FASN protein in 30 cases of bladder cancer and 15 cases of normal bladder tissues were detected by Immunohistochemistry. FASN siRNA and nonsense siRNA were transfected into UMUC3 cell lines by lipofectamine 2000 respectively, and the stable siFASN and siControl cell lines were successfully obtained after screening and identification for several times. The siFASN cell lines were set as the experimental group, while the siControl cell lines were set as the control group. The expressions of FASN protein and mRNA in the experimental group and the control group were detected by Western blot and real-time quantitative PCR (RT-PCR) respectively. Cell proliferation activities in two groups were detected by MTT assay and cell invasion and migration in two groups were detected by cell scratch test and Transwell invasive assays respectively. Results: FASN protein was overexpressed in bladder cancer tissues, and it was closely correlated with pathological stage and grade (P＜0.05). Compared with the siControl group, the expressions of FASN mRNA and protein in the siFASN group cell lines were decreased significantly (P＜0.05). The cell proliferation ability, the migration ability and the number of transmembrane cells of siFASN group cell lines were reduced significantly (P＜0.05). Conclusion: The FASN overexpression may play an essential role in the development and progression of bladder cancer. Down-regulation of FASN expression can inhibit the proliferation, migration and invasion of bladder cancer cells, and inhibition of FASN expression is expected to be a new treatment for bladder cancer.

Key words: fatty acid synthase, bladder cancer, cell proliferation, cell invasion, cell migration

中图分类号:

颜新建, 李高峰, 唐梅, 杨小平. 下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响^*[J]. 中国应用生理学杂志, 2019, 35(6): 543-547.

YAN Xin-jian, LI Gao-feng, TANG Mei, YANG Xiao-ping. Effect of down-regulation of fatty acid synthase expression on proliferation, migration and invasion of bladder carcinoma UMUC3 cell lines[J]. CJAP, 2019, 35(6): 543-547.

参考文献

[1] Babjuk M. Trends in bladder cancer incidence and mortality: success or disappointment[J]? Eur Urol, 2017, 71(1): 109-110.
[2] Allina DO, Andreeva YY, Zavalishina LE, et al. Fatty acid synthase in the diagnosis of prostate neoplasms[J]. Arkh Patol, 2017, 79(2): 10-14.
[3] Giró-Perafita A, Sarrats A, Pérez-Bueno F, et al. Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer[J]. Oncotarget, 2017, 8(43): 74391-74405.
[4] Lee KH, Lee MS, Cha EY, et al. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis[J]. Mol Med Rep, 2017, 15(4): 2163-2173.
[5] Bian Y, Yu Y, Wang S, et al. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer[J]. Biochem Biophys Res Commun, 2015, 463(4): 612-617.
[6] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[7] Danhier P, Bański P, Payen VL, et al. Cancer metabolism in space and time: beyond the warburg effect[J]. Biochim Biophys Acta Bioenerg, 2017:. S0005272817300233.
[8] Hopperton KE, Duncan RE, Bazinet RP, et al. Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity[J]. Exp Cell Res, 2014, 320(2): 302-310.
[9] Jones SF, Infante JR. Molecular pathways: fatty acid synthase[J]. Clin Cancer Res, 2015, 21(24): 5434-5438.
[10]Sun L, Yao Y, Pan G, et al. Small interfering RNA-mediated knockdown of fatty acid synthase attenuates the proliferation and metastasis of human gastric cancer cells via the mTOR/Gli1 signaling pathway[J]. Oncol Lett, 2018, 16(1): 594-602.
[11]Gong J, Shen S, Yang Y, et al. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway[J]. Int J Oncol, 2017, 50(3): 883-892.
[12]邓雷弘, 徐芳华, 董志峰, 等. FASN在膀胱癌组织中的表达及其临床意义[J]. 临床泌尿外科杂志, 2018, 33(3): 203-207.
[13]Chang L, Wu P, Senthikumar R, et al. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway[J]. J Cancer Res and Clin Oncol, 2016, 142(1): 59-72.
[14]Long X, Zhang G, Peng A. et al. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro[J]. Oncol Rep, 2014, 31(1): 328-334.
[15]凌宏艳, 贺娟, 杨丝丝, 等. 槟榔碱对3T3-L1脂肪细胞脂代谢的影响[J]. 中国应用生理学杂志, 2017, 33(1): 22-25.
[16]Falchook G, Patel M, Infante J, et al. Abstract CT153: First in human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640[J]. Cancer Res, 2017, 77(13 Supplement): CT153-CT153.

下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响^*

Effect of down-regulation of fatty acid synthase expression on proliferation, migration and invasion of bladder carcinoma UMUC3 cell lines

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价

[1]	刘莉, 徐凯, 王禄强, 徐美丽. miR-155-3p对HANK1细胞EAF1 mRNA降解速率及恶性增殖的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 601-605.
[2]	樊小群, 李欢, 朱华雄, 黄健平, 何吕芬. Mir-335-5p靶向G6PD对结肠癌细胞增殖、凋亡的影响[J]. 中国应用生理学杂志, 2021, 37(4): 402-406.
[3]	刘久鹏, 邵淑丽, 何孟奇, 黄鑫, 张伟伟, 张珍珠, 陈亚楠. 桦木酸对人胃癌MGC-803细胞增殖的影响[J]. 中国应用生理学杂志, 2021, 37(3): 257-261.
[4]	陈亚楠, 邵淑丽, 何孟奇, 黄鑫, 张伟伟, 张珍珠. 桦木酸对人胃癌SGC-7901细胞增殖的影响^*[J]. 中国应用生理学杂志, 2020, 36(6): 628-632.
[5]	范有寿, 邱志胜, 赵亚萍. 硫氧还蛋白还原酶1(TrxR1)在胃癌中的表达及对胃癌细胞生长的影响^*[J]. 中国应用生理学杂志, 2020, 36(4): 324-329.
[6]	赵翔宇, 何振宇, 宰守峰. 人参皂苷Rg5对胃癌细胞周期和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(1): 51-54.
[7]	王凤杰, 宗星煜, 杜俊龙, 王文晟, 袁德培, 陈显兵. 二氢杨梅素对人胃癌MKN45细胞迁移和侵袭的影响及其机制^*[J]. 中国应用生理学杂志, 2019, 35(5): 428-432.
[8]	黄生辉, 巩婷, 李妍怡. 中风膏对氧糖剥夺/再复氧损伤大鼠海马神经干细胞增殖的影响[J]. 中国应用生理学杂志, 2018, 34(6): 554-557.